Chilcott, E;
Díaz, JA;
Bertram, C;
Berti, M;
Karda, R;
(2022)
Genetic therapeutic advancements for Dravet Syndrome.
Epilepsy & Behavior
, 132
, Article 108741. 10.1016/j.yebeh.2022.108741.
Preview |
PDF
1-s2.0-S1525505022001901-main.pdf - Published Version Download (396kB) | Preview |
Abstract
Dravet Syndrome is a genetic epileptic syndrome characterized by severe and intractable seizures associated with cognitive, motor, and behavioral impairments. The disease is also linked with increased mortality mainly due to sudden unexpected death in epilepsy. Over 80% of cases are due to a de novo mutation in one allele of the SCN1A gene, which encodes the α-subunit of the voltage-gated ion channel NaV1.1. Dravet Syndrome is usually refractory to antiepileptic drugs, which only alleviate seizures to a small extent. Viral, non-viral genetic therapy, and gene editing tools are rapidly enhancing and providing new platforms for more effective, alternative medicinal treatments for Dravet syndrome. These strategies include gene supplementation, CRISPR-mediated transcriptional activation, and the use of antisense oligonucleotides. In this review, we summarize our current knowledge of novel genetic therapies that are currently under development for Dravet syndrome.
Type: | Article |
---|---|
Title: | Genetic therapeutic advancements for Dravet Syndrome |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.yebeh.2022.108741 |
Publisher version: | https://doi.org/10.1016/j.yebeh.2022.108741 |
Language: | English |
Additional information: | © 2022 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
Keywords: | Dravet Syndrome, Epilepsy, Gene therapy, SCN1A, Severe Myoclonic Epilepsy of Infants, Treatment |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health > Maternal and Fetal Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences |
URI: | https://discovery.ucl.ac.uk/id/eprint/10150201 |
Archive Staff Only
View Item |